1. |
Lizneva D, Suturina L, Walker W, et al. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril, 2016, 106(1): 6-15.
|
2. |
Meier RK. Polycystic ovary syndrome. Nurs Clin North Am, 2018, 53(3): 407-420.
|
3. |
Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol, 2018, 14(5): 270-284.
|
4. |
齐玉涵, 刘泽鹏, 张伟杰, 等. 环状 RNA 研究进展. 生理学报, 2019, 71(4): 613-624.
|
5. |
Chen LL, Yang L. Regulation of circRNA biogenesis. RNA Biol, 2015, 12(4): 381-388.
|
6. |
高嘉良, 陈光, 何浩强, 等. 环状 RNA: 人类疾病研究的新领域. 中国中药杂志, 2018, 43(3): 457-462.
|
7. |
Qian L, Yu S, Chen Z, et al. The emerging role of circRNAs and their clinical significance in human cancers. Biochim Biophys Acta Rev Cancer, 2018, 1870(2): 247-260.
|
8. |
Deng L, Chen Q, Xie J, et al. circPUM1 promotes polycystic ovary syndrome progression by sponging to miR-760. Gene, 2020, 754: 144903.
|
9. |
Cooper DA, Cortés-López M, Miura P. Genome-wide circRNA profiling from RNA-seq data. Methods Mol Biol, 2018, 1724: 27-41.
|
10. |
Sanger HL, Klotz G, Riesner D, et al. Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures. Proc Natl Acad Sci USA, 1976, 73(11): 3852-3856.
|
11. |
Aghaee-Bakhtiari SH. Online databases and circular RNAs. Adv Exp Med Biol, 2018, 1087: 35-38.
|
12. |
Li Y, Chen C, Ma Y, et al. Multi-system reproductive metabolic disorder: significance for the pathogenesis and therapy of polycystic ovary syndrome (PCOS). Life Sci, 2019, 228: 167-175.
|
13. |
Jiao J, Shi B, Wang T, et al. Characterization of long non-coding RNA and messenger RNA profiles in follicular fluid from mature and immature ovarian follicles of healthy women and women with polycystic ovary syndrome. Hum Reprod, 2018, 33(9): 1735-1748.
|
14. |
Li Y, Zhang J, Liu YD, et al. Long non-coding RNA TUG1 and its molecular mechanisms in polycystic ovary syndrome. RNA Biol, 2020, 17(12): 1798-1810.
|
15. |
Wang W, Ji J, Li J, et al. Several critical genes and microRNAs associated with the development of polycystic ovary syndrome. Ann Endocrinol (Paris), 2020, 81(1): 18-27.
|
16. |
Liu J, Ding J, Qu B, et al. CircPSMC3 alleviates the symptoms of PCOS by sponging miR-296-3p and regulating PTEN expression. J Cell Mol Med, 2020, 24(18): 11001-11011.
|
17. |
Wang LP, Peng XY, Lv XQ, et al. High throughput circRNAs sequencing profile of follicle fluid exosomes of polycystic ovary syndrome patients. J Cell Physiol, 2019, 234(9): 15537-15547.
|
18. |
Palomba S, Daolio J, La Sala GB. Oocyte competence in women with polycystic ovary syndrome. Trends Endocrinol Metab, 2017, 28(3): 186-198.
|
19. |
Kung CP, Leu JI, Basu S, et al. The P72R polymorphism of p53 predisposes to obesity and metabolic dysfunction. Cell Rep, 2016, 14(10): 2413-2425.
|
20. |
Brunet A. Aging and the control of the insulin-FOXO signaling pathway. Med Sci (Paris), 2012, 28(3): 316-320.
|
21. |
Sen R, Ghosal S, Das S, et al. Competing endogenous RNA: the key to posttranscriptional regulation. Sci World J, 2014, 2014: 896206.
|
22. |
Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature, 2013, 495(7441): 333-338.
|
23. |
Jia C, Wang S, Yin C, et al. Loss of hsa_circ_0118530 inhibits human granulosa-like tumor cell line KGN cell injury by sponging miR-136. Gene, 2020, 744: 144591.
|
24. |
Ma Z, Zhao H, Zhang Y, et al. Novel circular RNA expression in the cumulus cells of patients with polycystic ovary syndrome. Arch Gynecol Obstet, 2019, 299(6): 1715-1725.
|
25. |
Song Y, Yu G, Xiang Y, et al. Altered miR-186 and miR-135a contribute to granulosa cell dysfunction by targeting ESR2: a possible role in polycystic ovary syndrome. Mol Cell Endocrinol, 2019, 494: 110478.
|
26. |
Tang FH, Chang W, Tsai EM, et al. Investigating novel genes potentially involved in endometrial adenocarcinoma using next-generation sequencing and bioinformatic approaches. Int J Med Sci, 2019, 16(10): 1338-1348.
|
27. |
Ying H, Lyu J, Ying T, et al. Risk miRNA screening of ovarian cancer based on miRNA functional synergistic network. J Ovarian Res, 2014, 7: 9.
|